The home of patient-enabled innovation
Introducing A.Catalyst Network
A.Catalyst Network is an interconnected and dynamic global network of more than 20 AstraZeneca health innovation hubs, made up of physical locations and virtual partnerships. Our collective ambition is to address current healthcare challenges, increase affordable and equitable access to healthcare and scale and showcase patient‑enabled innovation through partnerships within the health ecosystem.
Innovation in action: Our vision for the future of healthcare
We believe that patient experiences and outcomes are our shared responsibility, and that innovation doesn’t happen in isolation.
A.Catalyst Network brings together diverse stakeholders to forge non-traditional partnerships across geographical boundaries, facilitating collaborative action and opening up new opportunities to enhance patient-enabled innovation.
Through collaborative innovation, our ultimate aim is to strengthen and future-proof health systems across the whole patient journey, ensuring everyone has equitable and affordable access to the life-changing healthcare solutions they need, regardless of where they live.
Patients are at the centre of everything we do across A.Catalyst Network. You can find out more about our values and vision in our Video Manifesto.
Join our mission to shape the future of healthcare
Could you be our next partner? Do you have a proposal to submit for consideration by our A.Catalyst Network Hubs teams? If you have an ambition to improve outcomes for patients around the world, we want to know about it.
Our impact in numbers
solutions in development
solutions scaled after pilot
Our partners include
Patients | Healthcare practitioners | Governments and policy makers | Academia | Tech and pharma industries | Ecosystem builders | Investors | Entrepreneurs
Our focus areas
Artificial Intelligence (AI)
We are developing Artificial Intelligence (AI) solutions to support the screening, detection, diagnosis, staging and management of lung cancer, breast cancer and COPD, and to help healthcare professionals identify cardio-renal complications in type 2 diabetes patients. These solutions align with our Cardiovascular, Renal and Metabolism (CVRM), Oncology, and Respiratory & Immunology therapy areas, and aim to address unmet need in the prevention and awareness, diagnosis, treatment and post-treatment stages of the patient journey.
We are developing digital app solutions to help healthcare professionals analyse chest x-rays, and provide patients with online consultations, e-prescriptions and support in managing conditions such as asthma, diabetes, heart failure, breast cancer and lung cancer. These solutions align with our Cardiovascular, Renal and Metabolism (CVRM), Oncology, and Respiratory & Immunology therapy areas, and aim to address unmet need in the prevention and awareness, diagnosis, treatment, post-treatment and wellness stages of the patient journey.
We are developing co-incubation programmes to support biomedical tech start-ups engaged in the research and development of integrated oncology solutions, and offer coaching, co-working spaces, shared equipment, regulatory support, and financial subsidy. These programmes align with our Oncology therapy area and aim to address unmet need in the prevention and awareness, diagnosis, treatment, post-treatment and wellness stages of the patient journey.
At AstraZeneca, we are driven by science, united by science, and every day, we push the boundaries of science to deliver life-changing medicines.
Veeva ID: Z2-2660
Date of preparation: March 2022